
Oxford Immunotec Global PLC OXFD
Oxford Immunotec Global PLC EV - Enterprise Value 2011-2026 | OXFD
Annual EV - Enterprise Value Oxford Immunotec Global PLC
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 26.2 M | 13.1 M | 1.3 M | 2.32 M | 12.8 M | 35.8 M | 40.9 M | 36.2 M | 3.49 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 40.9 M | 1.3 M | 19.1 M |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Biodesix
BDSX
|
142 M | $ 15.21 | 3.54 % | $ 1.97 B | ||
|
Bioventus
BVS
|
1.01 B | $ 9.12 | 1.33 % | $ 608 M | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.12 | -0.47 % | $ 4.87 M | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 16.37 | 0.24 % | $ 495 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 75.01 | -0.96 % | $ 5.06 B | ||
|
Medpace Holdings
MEDP
|
14 B | $ 460.9 | 0.87 % | $ 13.3 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.77 | 2.36 % | $ 442 M | ||
|
National Research Corporation
NRC
|
432 M | $ 17.42 | -0.51 % | $ 390 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | ||
|
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.39 | -0.36 % | $ 417 M | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Precipio
PRPO
|
10.9 M | $ 26.85 | -0.3 % | $ 34.8 M | ||
|
Personalis
PSNL
|
229 M | $ 7.7 | 1.18 % | $ 456 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
RadNet
RDNT
|
7.26 B | $ 60.0 | -2.83 % | $ 4.51 B | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 159.79 | 1.13 % | $ 7.92 B | ||
|
IQVIA Holdings
IQV
|
49.6 B | $ 165.38 | -0.95 % | $ 28.4 B | ||
|
Senseonics Holdings
SENS
|
376 M | $ 6.74 | 1.81 % | $ 281 M | ||
|
Sotera Health Company
SHC
|
7.07 B | $ 13.89 | 0.07 % | $ 3.94 B | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
34.1 M | $ 1.24 | -15.07 % | $ 6.75 M | ||
|
Neuronetics
STIM
|
168 M | $ 1.49 | -7.19 % | $ 98.3 M | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 256.48 | 1.41 % | $ 25.9 B | ||
|
Interpace Biosciences
IDXG
|
19.7 M | $ 1.71 | 0.73 % | $ 7.5 M | ||
|
IDEXX Laboratories
IDXX
|
52.7 B | $ 574.14 | -0.76 % | $ 46.2 B | ||
|
Illumina
ILMN
|
15.3 B | $ 125.44 | 1.33 % | $ 19.9 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 101.04 | 0.68 % | $ 8.33 B | ||
|
Guardant Health
GH
|
15.2 B | $ 85.0 | 0.05 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 45.99 | 3.35 % | $ 2.75 B | ||
|
Celcuity
CELC
|
506 M | $ 103.41 | -3.13 % | $ 4.08 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 265.75 | 0.5 % | $ 22.1 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
ENDRA Life Sciences
NDRA
|
864 K | $ 3.36 | -3.45 % | $ 1.8 M | ||
|
NeoGenomics
NEO
|
1.85 B | $ 8.05 | -0.62 % | $ 1.03 B | ||
|
Natera
NTRA
|
5.53 B | $ 195.23 | -2.43 % | $ 19.2 B | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 17.58 | 0.11 % | $ 937 M |